Robert Blum | Investor Relations |
Steve Shum | Chief Executive Officer |
Mike Campbell | Chief Operating and Vice President, Business Development |
Andrea Goren | Chief Financial Officer |
Good afternoon. And welcome, to the INVO Bioscience Second Quarter Fiscal Year 2023 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Robert Blum of Lytham Partners.